July 17, 2020
Orexo Interim Report Q2 2020
Media
July 17, 2020
BONESUPPORT HOLDING AB (publ) – Publishes Q2 2020 Interim report
July 10, 2020
BONESUPPORT HOLDING AB (publ) – Interim Report Q2 2020 – invitation to conference call and webcast
July 10, 2020
GenSight Biologics obtains a €7m non-dilutive loan and renegotiates the bond agreement with Kreos Capital extending runway to mid-2021
July 07, 2020
GenSight Biologics reports sustained efficacy and safety among LHON patients three years after LUMEVOQ® treatment
July 03, 2020
Vicore Pharma has completed a directed share issue of SEK 185 million
July 02, 2020
Vicore Pharma intends to carry out a directed share issue
July 02, 2020
GenSight Biologics to Host LUMEVOQ® Key Opinion Leader Call on July 9, 2020
July 02, 2020
Invitation to attend a teleconference on July 2, 1.30 pm CET – DTx US commercialization plan
July 02, 2020
Orexo launches deprexis® and vorvida® in the US and provides updated financial guidance
